Sodium channels and nociception: recent concepts and therapeutic opportunities
- PMID: 17964852
- DOI: 10.1016/j.coph.2007.09.007
Sodium channels and nociception: recent concepts and therapeutic opportunities
Abstract
Recent scientific advances have enhanced our understanding of the role voltage-gated sodium channels play in pain sensation. Human data on Nav1.7 show that gain-of-function mutations lead to enhanced pain while loss-of-function mutations lead to Congenital Indifference to Pain. Pre-clinical data from knockouts, anti-sense oligonucleotides, and siRNA for Nav1.3, 1.7, 1.8, and 1.9 have also demonstrated that specific subtypes of voltage-gated sodium channels play a role in different types of pain signaling. In addition, recent reports show that CNS penetration by voltage-gated sodium channel blockers is not required for efficacy in pre-clinical pain models while others have reported that identification of subtype-selective small molecules is possible. All of these data are converging to suggest next generation sodium channel blockers may offer the potential for novel pain therapies in the future.
Similar articles
-
Future potential and status of selective sodium channel blockers for the treatment of pain.Curr Opin Drug Discov Devel. 2009 Sep;12(5):682-92. Curr Opin Drug Discov Devel. 2009. PMID: 19736626 Review.
-
Voltage-gated sodium channels and pain pathways.J Neurobiol. 2004 Oct;61(1):55-71. doi: 10.1002/neu.20094. J Neurobiol. 2004. PMID: 15362153 Review.
-
The role of tetrodotoxin-resistant sodium channels in pain states: are they the next target for analgesic drugs?Curr Opin Investig Drugs. 2008 Jan;9(1):83-9. Curr Opin Investig Drugs. 2008. PMID: 18183535 Review.
-
Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.J Med Chem. 2008 Feb 14;51(3):407-16. doi: 10.1021/jm070637u. Epub 2008 Jan 5. J Med Chem. 2008. PMID: 18176998
-
The role of voltage-gated sodium channels in neuropathic pain.Curr Opin Neurobiol. 2003 Jun;13(3):291-7. doi: 10.1016/s0959-4388(03)00074-6. Curr Opin Neurobiol. 2003. PMID: 12850213 Review.
Cited by
-
Colonic Hypersensitivity and Sensitization of Voltage-gated Sodium Channels in Primary Sensory Neurons in Rats with Diabetes.J Neurogastroenterol Motil. 2016 Jan 31;22(1):129-40. doi: 10.5056/jnm15091. J Neurogastroenterol Motil. 2016. PMID: 26459453 Free PMC article.
-
The perception and endogenous modulation of pain.Scientifica (Cairo). 2012;2012:561761. doi: 10.6064/2012/561761. Epub 2012 Dec 25. Scientifica (Cairo). 2012. PMID: 24278716 Free PMC article. Review.
-
Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics.Br J Pharmacol. 2014 May;171(10):2508-27. doi: 10.1111/bph.12532. Br J Pharmacol. 2014. PMID: 24283624 Free PMC article. Review.
-
Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.Clin Transl Sci. 2017 Sep;10(5):337-350. doi: 10.1111/cts.12464. Epub 2017 Apr 18. Clin Transl Sci. 2017. PMID: 28419765 Free PMC article. Review. No abstract available.
-
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adults.Pain Med. 2021 Aug 6;22(8):1814-1826. doi: 10.1093/pm/pnab032. Pain Med. 2021. PMID: 33543763 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical